Chandarlapaty, S., & Razavi, P. (2019). Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors. J Clin Oncol.
Chicago-stil citatChandarlapaty, Sarat, och Pedram Razavi. "Cyclin E MRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors." J Clin Oncol 2019.
MLA-referensChandarlapaty, Sarat, och Pedram Razavi. "Cyclin E MRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors." J Clin Oncol 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.